4 results match your criteria: "Chemical Abuse Centers Inc.[Affiliation]"
JONAS Healthc Law Ethics Regul
December 2000
Chemical Abuse Centers Inc., Yale University, USA.
Am Fam Physician
May 2000
Chemical Abuse Centers Inc, Austintown, Canton, Ohio, USA.
The symptomatic effects of drug abuse are a result of alterations in the functioning of the following neurotransmitters or their receptors: acetylcholine, dopamine, gamma-aminobutyric acid, norepinephrine, opioids and serotonin. Anticholinergic drugs antagonize acetylcholine receptors. Dissociative drugs affect all transmitter sites.
View Article and Find Full Text PDFPsychiatry Res
February 2000
Chemical Abuse Centers Inc., 721 Boardman-Poland Road, Suite 200, Boardman, OH 44512-5105, USA.
The authors compared the antimanic effects of a verapamil-magnesium oxide (V-M) combination with a verapamil-placebo combination (V-P) in patients pretreated with verapamil. BPRS scores and serum magnesium levels were compared. The V-M combination was found to be significantly more effective than V-P in reducing manic symptoms (P=0.
View Article and Find Full Text PDFAm J Ther
July 1995
Ohio State University, OH, USA and Chemical Abuse Centers Inc., OH, USA.
A patient addicted to khat was successfully treated as an outpatient. He was detoxified with bromocriptine mesylate 1.25 mg.
View Article and Find Full Text PDF